Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cognitive Impairment in Parkinson’s Disease: Epidemiology, Clinical Profile, Protective and Risk Factors
Paulina González-Latapí, Ece Bayram, Irene Litvan, et al.
Behavioral Sciences (2021) Vol. 11, Iss. 5, pp. 74-74
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Sex and Gender Differences in Parkinson's Disease
Roshni Patel, Katie Kompoliti
Neurologic Clinics (2023) Vol. 41, Iss. 2, pp. 371-379
Closed Access | Times Cited: 35
Evaluation of curcumin as add-on therapy in patients with Parkinson's disease: A pilot randomized, triple-blind, placebo-controlled trial
Hamidreza Ghodsi, Hamid Reza Rahimi, Seyedeh Mehrnaz Aghili, et al.
Clinical Neurology and Neurosurgery (2022) Vol. 218, pp. 107300-107300
Closed Access | Times Cited: 32
Recombinant Adeno-Associated Virus Vectors for Gene Therapy of the Central Nervous System: Delivery Routes and Clinical Aspects
Żaneta Słyk, Natalia Stachowiak, Maciej Małecki
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1523-1523
Open Access | Times Cited: 7
Cascaded Deep Learning Frameworks in Contribution to the Detection of Parkinson’s Disease
Nalini Chintalapudi, Gopi Battineni, Mohammad Amran Hossain, et al.
Bioengineering (2022) Vol. 9, Iss. 3, pp. 116-116
Open Access | Times Cited: 23
The Increase of Theta Power and Decrease of Alpha/Theta Ratio as a Manifestation of Cognitive Impairment in Parkinson’s Disease
Katarzyna Zawiślak-Fornagiel, Daniel Ledwoń, Monika Bugdol, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1569-1569
Open Access | Times Cited: 13
Association Between Baseline Gait Parameters and Future Fall Risk in Patients With De Novo Parkinson’s Disease: Forward Versus Backward Gait
Kyum‐Yil Kwon, Jihwan You, Rae On Kim, et al.
Journal of Clinical Neurology (2024) Vol. 20, Iss. 2, pp. 201-201
Open Access | Times Cited: 4
Emerging biophysical techniques for probing synaptic transmission in neurodegenerative disorders
Mayur B. Kale, Nitu L. Wankhede, Ashok Kumar Bishoyi, et al.
Neuroscience (2024) Vol. 565, pp. 63-79
Closed Access | Times Cited: 4
Associations between frailty and cognitive impairment in Parkinson´s disease: a cross-sectional study
M. C. Sousa-Fraguas, Gustavo Rodríguez Fuentes, D. Lastra-Barreira, et al.
Aging Clinical and Experimental Research (2025) Vol. 37, Iss. 1
Open Access
Patterns of BDNF expression in the dorsal striatum and cognitive processing areas during aging in a progressive model of parkinsonism
Mylaine S. Mendonça, João E.C. Melo, Heitor S. Franco, et al.
(2025), pp. 202485-202485
Closed Access
Executive dysfunction in Parkinson's disease: From neurochemistry to circuits, genetics and neuroimaging
Shuyan Tong, Ruiwen Wang, Hui‐Hua Li, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111272-111272
Closed Access
Progress and prospects of Parkinson’s disease with depression research: A global bibliometric analysis based on CiteSpace
Jianling Li, Jianhang You, Zhigang Li, et al.
Medicine (2025) Vol. 104, Iss. 7, pp. e41537-e41537
Open Access
Lifestyle Interventions and Innovative Approaches for the Management of Neurodegenerative Disorders in Older Adults—State-Of-The-Art and Future Directions
Iuliana Popescu, Manon Lenain, Erika Rovini, et al.
American Journal of Lifestyle Medicine (2025)
Closed Access
Race and Ethnicity in Lewy Body Dementia: A Narrative Review
Ece Bayram, Samantha K. Holden, Michelle Fullard, et al.
Journal of Alzheimer s Disease (2023) Vol. 94, Iss. 3, pp. 861-878
Open Access | Times Cited: 11
Accelerated long-term forgetting in neurodegenerative disorders: A systematic review of the literature
Marta Rodini, Maria Stefania De Simone, Carlo Caltagirone, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 141, pp. 104815-104815
Closed Access | Times Cited: 17
Alpha-Synuclein: The Spark That Flames Dopaminergic Neurons, In Vitro and In Vivo Evidence
Alexandre Henriques, Laura Rouvière, Elodie Giorla, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9864-9864
Open Access | Times Cited: 16
Robotic technology for Parkinson's disease: Needs, attitudes and concerns of individuals with Parkinson's disease and their family members. A focus group study
Azriel Kaplan, Shirel Barkan-Slater, Yair Zlotnik, et al.
International Journal of Human-Computer Studies (2023) Vol. 181, pp. 103148-103148
Open Access | Times Cited: 10
Nonlinear Weighting Ensemble Learning Model to Diagnose Parkinson’s Disease Using Multimodal Data
Diego Castillo-Barnés, Francisco J. Martínez-Murcia, C. Jiménez-Mesa, et al.
International Journal of Neural Systems (2023) Vol. 33, Iss. 08
Open Access | Times Cited: 8
Calprotectin in Parkinsonian disease: Anticipation and dedication
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Ayah Talal Zaidalkiani, et al.
Ageing Research Reviews (2023) Vol. 93, pp. 102143-102143
Closed Access | Times Cited: 7
Protective effect of sterubin against neurochemical and behavioral impairments in rotenone-induced Parkinson's disease
May Alqurashi, Fahad A. Al‐Abbasi, Muhammad Afzal, et al.
Brazilian Journal of Medical and Biological Research (2024) Vol. 57
Open Access | Times Cited: 2
Novel Findings on CCR1 Receptor in CNS Disorders: A Pathogenic Marker Useful in Controlling Neuroimmune and Neuroinflammatory Mechanisms in Parkinson’s Disease
Alberto Repici, Anna Paola Capra, Ahmed Hasan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4337-4337
Open Access | Times Cited: 2
Update on Therapeutic potential of emerging nanoformulations of phytocompounds in Alzheimer's and Parkinson's disease
Neha Kanojia, Komal Thapa, Gagandeep Kaur, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 79, pp. 104074-104074
Closed Access | Times Cited: 12
Establishing Equivalent Aerobic Exercise Parameters Between Early-Stage Parkinson’s Disease and Pink1 Knockout Rats
Michael F. Salvatore, Isabel Soto, Ella A. Kasanga, et al.
Journal of Parkinson s Disease (2022) Vol. 12, Iss. 6, pp. 1897-1915
Open Access | Times Cited: 11
Lower Blood Lipid Level Is Associated with the Occurrence of Parkinson’s Disease: A Meta-Analysis and Systematic Review
Xue Hong, Wenting Guo, Shanshan Li
International Journal of Clinical Practice (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 10
Remote self-administration of digital cognitive tests using the Brief Assessment of Cognition: Feasibility, reliability, and sensitivity to subjective cognitive decline
Alexandra S. Atkins, Michael Kraus, Matthew Welch, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 9
Association between loneliness and cognitive function, and brain volume in community-dwelling elderly
Hunju Lee, Sang Yeol Yong, Hyowon Choi, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top